Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes

被引:6
|
作者
Wang, Yuying [1 ,2 ]
Wen, Lina [1 ,2 ]
Tang, Huazhen [1 ,2 ]
Qu, Jinxiu [1 ,2 ]
Rao, Benqiang [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China
[2] Beijing Shijitan Hosp, Key Lab Canc FSMP State Market Regulat, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
type; 2; diabetes; probiotics; prebiotics; microbiota; INTERNATIONAL SCIENTIFIC ASSOCIATION; CONSENSUS STATEMENT; MELLITUS; YOGURT; ADULTS; SCOPE;
D O I
10.33073/pjm-2023-013
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In modern lifestyles, high-fat diets and prolonged inactivity lead to more people developing type 2 diabetes (T2D). Based on the modern pathogenesis of T2D, food, and its components have become one of the top concerns for patients. Recent studies have found that dysbiosis and gut-related inflammation are more common in T2D patients. Probiotics and prebiotics play complementary roles in the gut as dietary supplements. Together, they may help improve dysbiosis and intestinal inflammation in people with T2D, increase the production of blood glucose-lowering hormones such as incretin, and help reduce insulin resistance and lower blood glucose. Therefore, changing the dietary structure and increasing the intake of probiotics and prebiotics is expected to become a new strategy for the adjuvant treatment of T2D.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
  • [31] Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials
    Tiderencel, Kelly A.
    Hutcheon, Deborah A.
    Ziegler, Jane
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (01)
  • [32] Prebiotics in food and dietary supplements: a roadmap to EU health claims
    Tuohy, Kieran
    Vaughan, Elaine E.
    Harthoorn, Lucien F.
    Blaak, Ellen E.
    Burnet, Philip W. J.
    Busetti, Alessandro
    Chakrabarti, Anirikh
    Delzenne, Nathalie
    de Vos, Paul
    Dye, Louise
    Guillemet, Damien
    Houghton, Lesley A.
    Kardinaal, Alwine F. M.
    Mersh, Cath
    Musa-Veloso, Kathy
    Nielsen, Annegret
    Palasinska, Justyna
    Salminen, Seppo
    Walton, Gemma
    Venlet, Naomi
    Hubermont, Charlotte
    Calder, Philip C.
    GUT MICROBES, 2024, 16 (01)
  • [33] Probiotics as adjunctive treatment in cystic fibrosis
    Guarino, A
    Spagnuolo, MI
    Valeria, R
    GASTROENTEROLOGY, 1999, 116 (04) : A885 - A885
  • [34] Application of dietary supplements in the prevention of type 2 diabetes-related cardiovascular complications
    Jin, Yannan
    Arroo, Randolph R. J.
    PHYTOCHEMISTRY REVIEWS, 2021, 20 (01) : 181 - 209
  • [35] Application of dietary supplements in the prevention of type 2 diabetes-related cardiovascular complications
    Yannan Jin
    Randolph R. J. Arroo
    Phytochemistry Reviews, 2021, 20 : 181 - 209
  • [36] Dietary triterpenes in the treatment of type 2 diabetes: To date
    Teng, Hui
    Yuan, Benyao
    Gothai, Sivapragasam
    Arulselvan, Palanisamy
    Song, Xinjie
    Chen, Lei
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 72 : 34 - 44
  • [37] Harnessing Prebiotics to Improve Type 2 Diabetes Outcomes
    Iatcu, Oana C.
    Hamamah, Sevag
    Covasa, Mihai
    NUTRIENTS, 2024, 16 (20)
  • [38] Dietary Supplements in Patients with Diabetes
    Koessler, Theresa
    Weber, Katharina
    Muessig, Karsten
    AKTUELLE ERNAHRUNGSMEDIZIN, 2019, 44 (06): : 422 - 429
  • [39] Dietary Supplements for Patients with Diabetes
    van Gemert, Theresa
    Weber, Katharina
    Muessig, Karsten
    DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (01) : 35 - 45
  • [40] Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
    Yadegarfar, Ghasem
    Livingston, Mark
    Cortes, Gabriela
    Alshames, Ramadan
    Leivesley, Kate
    Metters, Ann
    Horne, Linda
    Steele, Tom
    Heald, Adrian H.
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2021, 10 (02): : 132 - 136